Could a pill revive desire after breast cancer?

NCT ID NCT03707340

First seen Nov 05, 2025 · Last updated May 08, 2026 · Updated 25 times

Summary

This study looks at whether flibanserin, a drug for low sexual desire, can be safely taken by breast cancer survivors who are on hormone therapies like tamoxifen. About 43 women with a history of breast cancer and no current disease will take flibanserin for 24 weeks. The main goal is to see how many women can stay on the drug without stopping due to side effects, and whether it helps improve their sexual desire.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Memorial Sloan - Kettering Cancer Center

    New York, New York, 10021, United States

  • Memorial Sloan Kettering Basking Ridge

    Basking Ridge, New Jersey, 07920, United States

  • Memorial Sloan Kettering Cancer Center @ Commack

    Commack, New York, 11725, United States

  • Memorial Sloan Kettering Monmouth

    Middletown, New Jersey, 07748, United States

  • Memorial Sloan Kettering Nassau

    Uniondale, New York, 11553, United States

  • Memorial Sloan Kettering Westchester

    Harrison, New York, 10604, United States

  • Norwalk Hospital

    Norwalk, Connecticut, 06850, United States

Conditions

Explore the condition pages connected to this study.